Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00747773 · ClinicalTrials.gov registry record · Phase 4
Cryospray Ablation of Surgical Resection Specimens To Determine Safety And Histological Effect In The Lung
A Phase 4 study, sponsored by CSA Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT00747773: Completed Phase 4 study, sponsored by CSA Medical.
NCT00747773 is a Phase 4 study that has completed, run by CSA Medical. The registered enrollment target is 21 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00747773, a Phase 4 study, has completed, sponsored by CSA Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility and general safety in the human airway as well as assess the safety and depth and area of treatment using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchoscopy (FFB) using surgical resection specimens from patients undergoing lobectomy.
Interventions
- DEVICE CryoSpray Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
What the finished NCT00747773 record still lists
NCT00747773 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which CryoSpray Ablation System is the first listed.
NCT00747773 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00747773 about?
NCT00747773 is a clinical study titled "Cryospray Ablation of Surgical Resection Specimens To Determine Safety And Histological Effect In The Lung". The purpose of this study is to evaluate the feasibility and general safety in the human airway as well as assess the safety and depth and area of treatment using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchoscopy (FFB) using surgical resection specimens from patients u...
What is the current status of trial NCT00747773?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2007-11. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00747773?
The interventions under investigation include: CryoSpray Ablation System (DEVICE).
Who is sponsoring clinical trial NCT00747773?
This trial is sponsored by CSA Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00747773's enrollment target sits among peer trials
21 1742nd of 2000 higher than 248 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia